Detalhe da pesquisa
1.
Association of Alanine Aminotransferase Flares to Hepatitis B Surface Decline During Tenofovir Alone or With Pegylated Interferon Alfa.
Am J Gastroenterol
; 118(11): 2075-2079, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37307571
2.
Randomized Trial of Tenofovir With or Without Peginterferon Alfa Followed by Protocolized Treatment Withdrawal in Adults With Chronic Hepatitis B.
Am J Gastroenterol
; 118(7): 1214-1225, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599136
3.
Entecavir and Peginterferon Alfa-2a in Adults With Hepatitis B e Antigen-Positive Immune-Tolerant Chronic Hepatitis B Virus Infection.
Hepatology
; 69(6): 2338-2348, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30549279
4.
Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C.
Gut
; 63(1): 161-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23396509
5.
What the infectious disease physician needs to know about pegylated interferon and ribavirin.
Clin Infect Dis
; 56(11): 1629-36, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23429551
6.
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders.
Gastroenterology
; 140(3): 830-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20854821
7.
Maintenance peginterferon therapy and other factors associated with hepatocellular carcinoma in patients with advanced hepatitis C.
Gastroenterology
; 140(3): 840-9; quiz e12, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21129375
8.
Reduction in Hepatic Inflammation Is Associated With Less Fibrosis Progression and Fewer Clinical Outcomes in Advanced Hepatitis C.
Am J Gastroenterol
; 107(9): 1388-98, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22688849
9.
Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon.
Hepatology
; 53(4): 1100-8, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-21480316
10.
A prospective study of the rate of progression in compensated, histologically advanced chronic hepatitis C.
Hepatology
; 54(2): 396-405, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21520194
11.
Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C.
Gastroenterology
; 138(7): 2321-31, 2331.e1-2, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211180
12.
Ribavirin improves early responses to peginterferon through improved interferon signaling.
Gastroenterology
; 139(1): 154-62.e4, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20303352
13.
Development and progression of portal hypertensive gastropathy in patients with chronic hepatitis C.
Am J Gastroenterol
; 106(5): 884-93, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21139575
14.
Outcome of sustained virological responders with histologically advanced chronic hepatitis C.
Hepatology
; 52(3): 833-44, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20564351
15.
Clearance of pegylated interferon by Kupffer cells limits NK cell activation and therapy response of patients with HBV infection.
Sci Transl Med
; 13(587)2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790025
16.
Management of untreated and nonresponder patients with chronic hepatitis C.
Semin Liver Dis
; 30(4): 348-60, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20960375
17.
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Gastroenterology
; 136(1): 138-48, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18848939
18.
Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.
Gastroenterology
; 137(6): 1986-94, 2009 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-19747918
19.
Editorial: Treatment of patients with HCV-related cirrhosis with peginterferon and ribavirin: Swinging the pendulum toward treatment.
Am J Gastroenterol
; 105(10): 2174-6, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20927065
20.
Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
Hepatology
; 49(6): 1828-37, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19291787